Researchers see benefits, little risk from renal denervation

10/29/2012 | MedPage Today

The use of renal nerve ablation to treat refractory high blood pressure appears to carry long-term benefits with little risk of adverse events, according to researchers from Australia's Baker Heart and Diabetes Institute in Melbourne who reported the findings at TCT 2012. Within a month, 69% of patients demonstrated a response to the treatment, and at the three-year mark, 94% of remaining study participants had responded.

View Full Article in:

MedPage Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR